1 |
High level expression and characterization of the recombinant immunotoxin DAB389-4D5 scFv targeting HER2/neu-positive ovarian carcinoma cells Wang Z, Zhang J, Wang XD, Wei DZ Process Biochemistry, 80, 26, 2019 |
2 |
Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum Jiao PY, Zhang J, Dong YG, Wei DZ, Ren YH Applied Microbiology and Biotechnology, 102(22), 9585, 2018 |
3 |
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial Chandramohan V, Pegram CN, Piao H, Szafranski SE, Kuan CT, Pastan IH, Bigner DD Applied Microbiology and Biotechnology, 101(7), 2747, 2017 |
4 |
Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cells Nand KN, Gupta JC, Panda AK, Jain SK Protein Expression and Purification, 106, 10, 2015 |
5 |
Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells Stocker M, Tur MK, Sasse S, Krussmann A, Barth S, Engert A Protein Expression and Purification, 28(2), 211, 2003 |